{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lisina-Prolina-Valina)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 il KPV?<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> \u00e8 il tripeptide Lys-Pro-Val \u2014 il frammento C-terminale antinfiammatorio dell'ormone stimolante i melanociti alfa (\u03b1-MSH). A differenza degli analoghi pi\u00f9 ampi della melanocortina, il KPV non ha <strong>attivit\u00e0 di pigmentazione<\/strong>; its signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation studies. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvere liofilizzata (o come fornito)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 il KPV?<\/h2>\n<p><strong>KPV<\/strong> \u00e8 l'abbreviazione in codice a tre lettere del <strong>tripeptide Lys-Pro-Val<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>antinfiammatorio<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects. Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory studies tripeptides. It is supplied as a high-purity lyophilized powder. For mechanism, IBD studies history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/it\/kpv-peptide-anti-inflammatory-guide\/\">KPV guide<\/a>. <\/p>\n<h2>Meccanismo d'Azione \u2014 Tre Vie Anti-Infiammatorie<\/h2>\n<p>L'attivit\u00e0 anti-infiammatoria di KPV opera attraverso almeno tre vie complementari, che convergono tutte nel ridurre la segnalazione infiammatoria senza influenzare altre funzioni dei melanocortine:<\/p>\n<ul>\n<li><strong>Inibizione di NFkB<\/strong> \u2014 KPV blocca la traslocazione di NFkB nel nucleo, prevenendo la trascrizione di citochine pro-infiammatorie tra cui TNF-alfa, IL-6, IL-1\u03b2 e IL-8. NFkB \u00e8 il regolatore principale dell'espressione genica infiammatoria, quindi bloccarne l'attivazione produce un ampio effetto anti-infiammatorio a monte.<\/li>\n<li><strong>Stabilizzazione dei mastociti<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in study models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation studies and topical skin-inflammation models.<\/li>\n<li><strong>Separazione peptide-vs-MSH<\/strong> \u2014 poich\u00e9 KPV \u00e8 solo il frammento C-terminale, esso <strong>non attiva MC1R<\/strong> (il recettore della pigmentazione) o MC4R (il recettore dell'eccitazione\/alimentazione). Ci\u00f2 separa meccanicamente l'attivit\u00e0 anti-infiammatoria dagli altri effetti dell'\u03b1-MSH \u2014 diverso dagli analoghi MC pi\u00f9 ampi come <a href=\"https:\/\/medsbase.com\/it\/melanotan-ii\/\">Melanotan II<\/a> o <a href=\"https:\/\/medsbase.com\/it\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical studies implication: KPV is a &#8220;clean&#8221; anti-inflammatory tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of studies using full-length MC agonists. <\/p>\n<h2>Published Evidence<\/h2>\n<p>KPV is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis studies<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation studies (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>Infiammazione allergica<\/strong> \u2014 mast-cell stabilization and histamine-release studies in allergy and atopy models<\/li>\n<li><strong>Infiammazione cutanea<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis study models; topical formulations appear in some protocols<\/li>\n<li><strong>Cicatrizzazione delle ferite<\/strong> \u2014 anti-inflammatory phase of wound-healing studies, often paired with <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> per una copertura combinata antinfiammatoria e di fattori di crescita<\/li>\n<li><strong>Infiammazione articolare<\/strong> \u2014 arthritis and joint-inflammation rodent study models<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 comunemente associato a <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue studies where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative studies<\/strong> \u2014 a confronto con <a href=\"https:\/\/medsbase.com\/it\/melanotan-ii\/\">Melanotan II<\/a> e <a href=\"https:\/\/medsbase.com\/it\/pt-141\/\">PT-141<\/a> per isolare gli effetti puramente antinfiammatori rispetto a quelli sui recettori MC<\/li>\n<\/ul>\n<p>Per un contesto pi\u00f9 ampio sui peptidi antinfiammatori e rigenerativi, consultare <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a>. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase offre KPV nelle seguenti dimensioni di flaconcini liofilizzati:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies, or topical\/oral routes for GI and skin contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Confronto \u2014 KPV vs altri peptidi antinfiammatori\/melanocortinici<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lunghezza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amminoacidi<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amminoacidi<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amminoacidi (ciclico)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Attivit\u00e0 primaria<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Solo antinfiammatoria<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Antinfiammatoria + riparazione tissutale + recettore GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonista MC ampio (MC1-5)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Attivit\u00e0 del recettore MC<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuna (solo C-terminale)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1, MC3, MC4, MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Effetto sulla pigmentazione<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (segnale primario)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Study applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">IBD, allergie, infiammazione cutanea<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Recupero di tendini, intestino, muscoli<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Melanogenesi, fotoprotezione<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation studies, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/it\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale, stabili fino a 36 mesi. Evitare cicli di congelamento-scongelamento della polvere. <strong>Procedura di ricostituzione:<\/strong> iniettare acqua batteriostatica lungo la parete laterale del flaconcino di peptidi come indicato nella tabella sopra. Agitare delicatamente \u2014 non <strong>not<\/strong> scuotere \u2014 e lasciare riposare per 5\u201310 minuti per una completa dissoluzione. La soluzione dovrebbe essere chiara e incolore. <strong>Dopo la ricostituzione:<\/strong> conservare in frigorifero a 2\u20138\u00a0\u00b0C e utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is KPV used for in studies?<\/h3>\n<p>KPV is used in studies investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>not<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>In cosa differisce KPV da Melanotan II o PT-141?<\/h3>\n<p>KPV \u00e8 solo il frammento C-terminale di tre aminoacidi dell'alfa-MSH, mentre Melanotan II e PT-141 sono analoghi dell'MSH completi o quasi completi. Ci\u00f2 significa che KPV ha <strong>nessuna attivit\u00e0 del recettore delle melanocortine<\/strong> e quindi nessun effetto sulla pigmentazione (MC1R), sull'eccitazione (MC4R) o sull'appetito (MC4R) \u2014 solo attivit\u00e0 antinfiammatoria tramite le vie NFkB e dei mastociti. <\/p>\n<h3>What is the typical KPV dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies. Some IBD and skin-inflammation uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg. <\/p>\n<h3>Il KPV \u00e8 approvato dalla FDA?<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related has informed melanocortin drug development broadly, but KPV itself remains. All KPV sold by peptide-studies suppliers is for clinical investigation only. <\/p>\n<h3>Can KPV be taken orally for IBD studies?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis studies. This makes it unusually flexible for GI-inflammation studies where oral delivery targets the GI tract directly. Study protocols vary by model \u2014 SC remains the dominant systemic route. <\/p>\n<h3>Come deve essere conservato il KPV?<\/h3>\n<p>Flaconcini liofilizzati: refrigerati a 2\u20138\u00a0\u00b0C nella confezione originale, stabili fino a 36 mesi. Soluzione ricostituita: refrigerata a 2\u20138\u00a0\u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h3>Come si ricostituisce il KPV?<\/h3>\n<p>Segui la tabella di ricostituzione sopra riportata. Aggiungi acqua batteriostatica lungo la parete laterale del flaconcino, agita delicatamente e attendi 5-10 minuti per la completa dissoluzione. Non <strong>not<\/strong> agitare. <\/p>\n<h3>Can KPV and BPC-157 be stacked in studies?<\/h3>\n<p>Yes \u2014 this is one of the most common studies combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> fornisce attivit\u00e0 di riparazione tissutale e fattori di crescita attraverso la via del VEGF. I meccanismi sono complementari piuttosto che sovrapposti. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase offre KPV in flaconcini liofilizzati da 5 mg e 10 mg. Ogni concentrazione \u00e8 disponibile in confezioni da 10, 20 o 30 flaconcini. Tutti i flaconcini sono forniti con una purezza HPLC del 99%+ e un certificato di analisi su richiesta. <\/p>\n<h3>Does KPV cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical doses. Long-term human safety data are not available. <\/p>\n<h3>Qual \u00e8 l'emivita del KPV?<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa. <\/p>\n<h3>How does KPV reduce inflammation in study models?<\/h3>\n<p>Il KPV \u00e8 il tripeptide C-terminale dell'\u03b1-MSH (ormone stimolante i melanociti alfa) e conserva gran parte dell'attivit\u00e0 antinfiammatoria del peptide genitore attraverso l'attivazione di MC1R. Nei modelli di colite e danno intestinale, il KPV riduce la segnalazione di NF-\u03baB, diminuisce la produzione di citochine pro-infiammatorie (IL-1\u03b2, IL-6, TNF-\u03b1) e promuove l'integrit\u00e0 della barriera epiteliale intestinale. Le sue piccole dimensioni facilitano l'assorbimento diretto da parte delle cellule epiteliali indipendentemente dalle proteine vettrici. <\/p>\n<h3>Posso ordinare il KPV per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce il KPV in tutto il mondo dalla nostra rete dedicata alla spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione dedicato. Gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/it\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/it\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selettivo della grelina \u2014 pulso pulito di GH senza cortisolo\/prolattina<\/li>\n<li><a href=\"\/it\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 Analogico GHRH con emivita prolungata<\/li>\n<li><a href=\"\/it\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leggi la nostra guida completa basata sull'evidenza: <a href=\"https:\/\/medsbase.com\/it\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory studies<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD studies history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Supporta la riparazione dei tessuti<br \/>\n\u2705 Riduce lo stress ossidativo<br \/>\n\u2705 Modula la risposta immunitaria<br \/>\n\u2705 Promuove la resilienza cellulare<br \/>\n\u2705 Migliora l'integrit\u00e0 epiteliale<\/p>\n<p><strong>KPV<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":["post-69013","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kpv","product_tag-lysine-proline-valine","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}